In March 2025, the company announced new designs to get a immediate-to-client supplying of its Wegovy weight loss drug. The company founded a completely new pharmacy, referred to as NovoCare, which would cost customers $499 monthly for access to the drug, less than half the price of the drug by way of other pharmaceutical distribution networks.[53]